Significant upregulation of key enzymes of the genome replication process (RRM2, ribonucleotide reductase regulatory subunit M2; MCM4, mini-chromosome maintenance complex component 4, etc.)was observed in MAL2 expressing cells, indicating enhanced demands for biological metabolism in NSCLC. The gene discussed is MAL2; the disease is non-small cell lung carcinoma.